Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord MSCs for Large Area Skin Burns
NCT02669199Phase 1Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2012
- Primary completion
- Dec 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of human umbilical cord mesenchymal stem cells in burn injury, sponsored by Chinese PLA General Hospital. Primary endpoint: Frequency of Adverse Events at 12 months. Started Jan 2012; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT02669199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669199.